Ovid Therapeutics Inc. (OVID) financial statements (2021 and earlier)

Company profile

Business Address 1460 BROADWAY
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:72774287
Cash and cash equivalents72423687
Short-term investments 355 
Other undisclosed cash, cash equivalents, and short-term investments (0)(0) 
Other undisclosed current assets3331
Total current assets:75804489
Noncurrent Assets
Property, plant and equipment0000
Prepaid expense003 
Other noncurrent assets0001
Other undisclosed noncurrent assets0000
Total noncurrent assets:1131
TOTAL ASSETS:76814889
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities171196
Accounts payable5342
Accrued liabilities12754
Deferred revenue2 
Due to related parties20  
Total current liabilities:221196
Noncurrent Liabilities
Liabilities, other than long-term debt100  
Deferred revenue10 
Due to related parties00  
Total noncurrent liabilities:100  
Total liabilities:321196
Stockholders' equity
Stockholders' equity attributable to parent44703983
Preferred stock00  
Common stock0000
Additional paid in capital338283191184
Accumulated other comprehensive income (loss) 0(0) 
Accumulated deficit(294)(213)(153)(101)
Total stockholders' equity:44703983
TOTAL LIABILITIES AND EQUITY:76814889

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Gross profit:13   
Operating expenses(94)(61)(53)(65)
Operating loss:(81)(61)(53)(65)
Nonoperating income 110
Net loss:(81)(60)(52)(65)
Other undisclosed net income attributable to parent0   
Net loss available to common stockholders, diluted:(81)(60)(52)(65)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(81)(60)(52)(65)
Other comprehensive income (loss)(0)0(0) 
Comprehensive loss:(81)(60)(52)(65)
Other undisclosed comprehensive income, net of tax, attributable to parent0   
Comprehensive loss, net of tax, attributable to parent:(81)(60)(52)(65)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: